We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Factors Associated With Mortality in Neonates

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01215461
First Posted: October 6, 2010
Last Update Posted: May 14, 2013
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Mednax Center for Research, Education and Quality
  Purpose
The purpose of this study is to better understand the factors associated with mortality and identify potentially preventable causes of death in neonates who die after receiving health care. As a result, an improved neonatal mortality classification system may be defined.

Condition
Neonatal Mortality

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Evaluation of Factors Associated With Mortality in Neonates

Further study details as provided by Mednax Center for Research, Education and Quality:

Primary Outcome Measures:
  • To better understand the factors associated with mortality and identify potentially preventable causes of death in neonates who die after receiving health care. [ Time Frame: neonatal outcomes ]

Enrollment: 645
Study Start Date: September 2010
Study Completion Date: October 2012
Primary Completion Date: September 2012 (Final data collection date for primary outcome measure)
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   22 Weeks to 44 Weeks   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Neonates for whom healthcare was provided.
Criteria

Inclusion Criteria:

  • Neonates for whom healthcare was provided
  • Born alive
  • Neonate greater than or equal to 22 0/7 weeks estimated gestational age

Exclusion Criteria:

  • Stillborn
  • Fetal demise
  • Neonates less than or equal to 21 6/7 weeks estimated gestational age
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01215461


Locations
United States, Alaska
Providence Alaska Medical Center
Anchorage, Alaska, United States, 99508
Sponsors and Collaborators
Mednax Center for Research, Education and Quality
  More Information

Responsible Party: Mednax Center for Research, Education and Quality
ClinicalTrials.gov Identifier: NCT01215461     History of Changes
Other Study ID Numbers: PDX-001-10
First Submitted: October 5, 2010
First Posted: October 6, 2010
Last Update Posted: May 14, 2013
Last Verified: May 2013

Keywords provided by Mednax Center for Research, Education and Quality:
Neonatal mortality
Preterm birth
Low gestational age
VLBW


To Top